Gutiérrez-García, Gonzalo http://orcid.org/0000-0003-4084-8279
Cibeira, María Teresa
Rovira, Montserrat
Fernández de Larrea, Carlos
Tovar, Natalia
Rodríguez-Lobato, Luis Gerardo http://orcid.org/0000-0001-5694-0921
Rosiñol, Laura
Marín, Pedro
Solano-Vega, Julio
Suárez-Lledó, María
Bataller, Alex http://orcid.org/0000-0002-6085-2745
Solano, María Teresa
de Llobet, Noemí
Domenech, Ariadna
Borràs, Nuria
Lozano, Miquel
Cid, Joan
Martínez, Carmen
Urbano-Ispizua, Álvaro
Esteve, Jordi
Carreras, Enric
Fernández-Avilés, Francesc
Bladé, Joan
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI12/01290, PI16/0423)
Generalitat de Catalunya (AGAUR 2017SGR-792)
Article History
Received: 13 November 2018
Revised: 2 January 2019
Accepted: 4 January 2019
First Online: 21 January 2019
Compliance with ethical standards
:
: Gonzalo Gutiérrez-García: honoraria from Gilead. María Teresa Cibeira: honoraria from Janssen, Celgene, and Amgen. Carlos Fernández de Larrea: honoraria from Janssen, Celgene, and Amgen; advisory boards: Janssen, Celgene, and Amgen; grants from: Janssen, Celgene, Amgen, and Takeda. Laura Rosiñol: honoraria from Janssen, Celgene, Amgen, and Takeda. The remaining authors declare that they have no conflict of interest.